BioLineRX Ltd (BLRX) is a publicly traded Healthcare sector company. As of September 4, 2026, BLRX trades at $2.70 with a market cap of $13.29M and a P/E ratio of 0.00. BLRX moved +0.00% today. Year to date, BLRX is -3.93%; over the trailing twelve months it is -24.23%. Its 52-week range spans $2.15 to $7.77. Rallies surfaces BLRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for BLRX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $2.70 |
| Market Cap | $13.29M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.77 |
| 52-Week Low | $2.15 |
| Volume | 2.22K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
BLRX analyst coverage data. Average price target: $0.00.